NYU Langone opens vascular-targeted photodynamic therapy trial to men with localized

[News]

NYU Langone Medical Center has begun a clinical trial offering vascular-targeted photodynamic therapy to patients with localized prostate cancer. This novel, minimally invasive procedure uses a light-activated drug to deliver light energy waves by way of laser fibers in order to destroy prostate cancer cells.

More... (http://www.news-medical.net/news/20100728/NYU-Langone-opens-vascular-targeted-photodynamic-therapy-trial-to-men-with-localized-prostate-cancer.aspx)